(Q34461028)

2 August 2017

The severity of toxic reactions to ephedra: comparisons to other botanical products and national trends from 1993-2002. (English)

1 reference

2 August 2017

1 reference

Toby Litovitz

4

0 references

Susan C. Smolinske

series ordinal

3

object named as

Susan Smolinske

1 reference

2 August 2017

Alan D Woolf

1

1 reference

PubMed ID

16235509

2 August 2017

William A Watson

series ordinal

2

1 reference

PubMed ID

16235509

2 August 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

2 August 2017

1 reference

2 August 2017

43

1 reference

2 August 2017

5

1 reference

2 August 2017

347-355

1 reference

Use of nonprescription weight loss products: results from a multistate survey

2 August 2017

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200066075

Ephedrine-type alkaloid content of nutritional supplements containing Ephedra sinica (Ma-huang) as determined by high performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200066075

Modulation of feeding by hypothalamic paraventricular nucleus alpha 1- and alpha 2-adrenergic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200066075

Effects of (-)-ephedrine on locomotion, feeding, and nucleus accumbens dopamine in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200066075

Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200066075

Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200066075

Non-prescription sympathomimetic agents and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200066075

Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200066075

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200066075

Herbal stimulant containing ephedrine has also caused psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200066075

Psychiatric complications of Ma-huang

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200066075

Over-the-counter stimulants: abuse and addiction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200066075

Nonpigmenting solitary fixed drug eruption caused by a Chinese traditional herbal medicine, ma huang (Ephedra Hebra), mainly containing pseudoephedrine and ephedrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200066075

Intracerebral haemorrhage and angiographic beading following ingestion of catecholaminergics

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200066075

Stroke associated with ephedrine use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200066075

Ischemic stroke in a user of thermadrene: a case study in alternative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200066075

Use of Ephedra-containing products and risk for hemorrhagic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200066075

Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200066075

Effect of a multicomponent, ephedra-containing dietary supplement (Metabolife 356) on Holter monitoring and hemostatic parameters in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200066075

The relative safety of ephedra compared with other herbal products

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200066075

Yohimbine: a new street drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-200066075

21 January 2018

Identifiers

DOI

10.1081/CLT-200066075

1 reference

2 August 2017

1 reference

PubMed ID

16235509